Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice

European Journal of Heart Failure

Volumn 7, Issue 5, 2005, Pages 710-721

  McMurray, John ^a   Cohen Solal, Alain ^b   Dietz, Rainer ^c   Eichhorn, Eric ^d   Erhardt, Leif ^e   Hobbs, F D Richard ^f   Krum, Henry ^g   Maggioni, Aldo ^h   McKelvie, Robert S ⁱ   Piña, Ileana L ^j   Soler Soler, Jordi ^k   Swedberg, Karl ^l  

^a WESTERN INFIRMARY   (United Kingdom)

^b BEAUJON HOSPITAL   (France)

^c Franz Volhard Klinik   (Germany)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f Department of Primary Care and General Practice ^*  (United Kingdom)

^g MONASH UNIVERSITY   (Australia)

^h ANMCO RESEARCH CENTER   (Italy)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

^k Manresa General Hospital   (Spain)

^l SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

ACE inhibitors; Aldosterone antagonists; Angiotensin receptor blockers; Beta blockers; Clinical recommendations; Digoxin; Eplerenone; Heart failure; Hydralazine; Isosorbide dinitrate; Pharmacology; Spironolactone; Treatment

Indexed keywords

ALDOSTERONE ANTAGONIST; AMILORIDE; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPLERENONE; FRUMIL; FUROSEMIDE PLUS TRIAMTERENE; METOPROLOL; NEBIVOLOL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM ION; POTASSIUM SPARING DIURETIC AGENT; RAMIPRIL; SPIRONOLACTONE; TRANDOLAPRIL; TRIAMTERENE; UNINDEXED DRUG; VERAPAMIL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANGIONEUROTIC EDEMA; BLOOD CHEMISTRY; BRADYCARDIA; CLINICAL TRIAL; COUGHING; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG SAFETY; DRUG USE; DYSPNEA; EDEMA; EVIDENCE BASED MEDICINE; FATIGUE; GYNECOMASTIA; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MASTALGIA; META ANALYSIS; MORBIDITY; MORTALITY; NEPHROTOXICITY; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BENZOPYRANS; BISOPROLOL; CAPTOPRIL; CARBAZOLES; DRUG THERAPY, COMBINATION; ENALAPRIL; ETHANOLAMINES; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HUMANS; INDOLES; LISINOPRIL; METOPROLOL; PRACTICE GUIDELINES; PROPANOLAMINES; RAMIPRIL; RECEPTORS, ANGIOTENSIN; SPIRONOLACTONE; STROKE VOLUME; TETRAZOLES; VALINE;

EID: 23744514591     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.07.002     Document Type: Review

References (82)

1. M.E. Whitcomb Why we must teach evidence-based medicine Acad Med 80 2005 1 2
2. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north Scandinavian enalapril survival study (CONSENSUS). The CONSENSUS trial study group N Engl J Med 316 1987 1429 1435
3. The Study of Left Ventricular Dysfunction (SOLVD) Investigators Effects of Enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
4. M. Packer, M.R. Bristow, and J.N. Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. carvedilol heart failure study group N Engl J Med 334 1996 1349 1355
5. The effect of digoxin on mortality and morbidity in patients with heart failure. The digitalis investigation group N Engl J Med 336 1997 525 533
6. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
7. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
8. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N Engl J Med 341 1999 709 717
9. A. Hjalmarson, S. Goldstein, and B. Fagerberg Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 2000 1295 1302
10. M. Packer, A.J. Coats, M.B. Fowler Carvedilol prospective randomized cumulative survival study group Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
11. J.N. Cohn, G. Tognoni Valsartan heart failure trial investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
12. A.P. Maggioni, I. Anand, S.O. Gottlieb Val-HeFT Investigators (Valsartan Heart Failure Trial) Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors J Am Coll Cardiol 40 2002 1414 1421
13. M. Packer, M.B. Fowler, E.B. Roecker Carvedilol prospective randomized cumulative survival (COPERNICUS) study group Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Circulation 106 2002 2194 2199
14. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland Carvedilol Or Metoprolol European Trial Investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomised controlled trial Lancet 362 2003 7 13
15. J.J. McMurray, J. Ostergren, K. Swedberg CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771
16. C.B. Granger, J.J. McMurray, S. Yusuf CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 2003 772 776
17. J.B. Young, M.E. Dunlap, M.A. Pfeffer Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials Circulation 110 2004 2618 2626
18. E. O'Meara, S. Solomon, and J. McMurray Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: assessment of Reduction in Mortality and Morbidity (CHARM) programme Eur Heart J 25 2004 1920 1926
19. A.L. Taylor, S. Ziesche, C. Yancy African-American Heart Failure Trial Investigators Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
20. M.D. Flather, M.C. Shibata, A.J. Coats SENIORS Investigators Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225
21. US Department of Health and Human Services Agency for Health Care Policy and Research. Heart Failure: evaluation and care of patients with left-ventricular systolic dysfunction 1994 The Agency Rockville (Clinical Practice Guideline No. 11). AHCPR Publication No. 94-0612
22. J. McMurray, I. Gyarfas, and N.K. Wenger Concise guide to the management of heart failure Am J Geriatr Cardiol 5 1996 13 30
23. New Zealand guidelines for the management of chronic heart failure. The National Heart Foundation of New Zealand Cardiac Society of Australia and New Zealand and the Royal New Zealand College of General Practitioners Working Party N Z Med J 110 1997 99 107
24. Heart Failure Society of America (HFSA). Practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches J Card Fail 5 1999 357 382
25. U.C. Hoppe, E. Erdmann Kommission Klinische Kardiologie Guidelines for the treatment of chronic heart failure. Issued by the executive committee of the German society of cardiology-heart and circulation research, compiled on behalf of the commission of clinical cardiology in cooperation with pharmaceutic commission of the German physicians' association Z Kardiol 90 2001 218 237
26. H. Krum National heart foundation of Australia and cardiac society of Australia and New Zealand chronic heart failure clinical practice guidelines Writing Panel. Guidelines for management of patients with chronic heart failure in Australia Med J Aust 174 2001 459 466 NOTE: these guidelines are currently under revision (H. Krum, personal communication)
27. S.A. Hunt, D.W. Baker, and M.H. Chin ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 2001 2101 2113
28. P. Liu, J.M. Arnold, I. Belenkie Canadian Cardiovascular Society The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure Can J Cardiol 19 2003 347 356
29. National Institute for Clinical Excellence (NICE). Clinical Guideline 5. Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. London July 2003. http://www.nice.org.uk/pdf/ Full_HF_Guideline.pdf.
30. W.L. Mosterd, and P.F. Rosier Guideline 'Chronic heart failure' Ned Tijdschr Geneeskd 148 2004 609 614
31. K. Swedberg, J. Cleland, and H. Dargie Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 11 2005 Jun 1115 1140
32. T.J. Bungard, F.A. McAlister, J.A. Johnson, and R.T. Tsuyuki Underutilisation of ACE inhibitors in patients with congestive heart failure Drugs 61 2001 2021 2033
33. F.D. Hobbs, M.I. Jones, and T.F. Allan European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF) Eur Heart J 21 2000 1877 1887
34. J.G.F. Cleland, A. Cohen-Solal, and J.C. Aguilar Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 2002 1631 1639
35. M. Komajda, F. Follath, K. Swedberg Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe: Part 2. Treatment Eur Heart J 24 2003 464 474
36. D.N. Juurlink, M.M. Mamdani, and D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551
37. M. Svensson, F. Gustafsson, and S. Galatius Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study Br Med J 327 2003 1141 1142
38. F.S. Mair, T.S. Crowleu, and P.E. Brundred Prevalence, aetiology and management of heart failure in general practice Br J Gen Pract 46 1996 77 79
39. A. Houghton, and A. Cowley Why are angiotensin converting enzyme inhibitors underutilized in the treatment of heart failure by general practitioners? In JK Cardiol 59 1997 7 10
40. E.F. Philbin, C. Andreou, and T.A. Rocco Patterns of angiotensin- converting enzyme inhibitors use in congestive heart failure in two community hospitals Am J Cardiol 77 1996 832 838
41. N.L. Smith, B.M. Psaty, and B. Pitt Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995 Arch Intern Med 158 1998 1074 1080
42. S.E. Reis, R. Holubkov, and D. Edmundosicz Treatment of patients admitted to the hospital with congestive heart failure: speciality-related disparities in practice patterns and outcomes J Am Coll Cardiol 30 1997 733 738
43. M.J. Lenzen, O.P. Scholte, and W.J. Reimer Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220
44. P.J. Boyles, G.M. Peterson, M.D. Bleasel, and J.H. Vial Undertreatment of congestive heart failure in an Australian setting J Clin Pharm Ther 29 2004 15 22
45. F.A. Masoudi, S.S. Rathore, and Y. Wang National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction Circulation 110 2004 724 731
46. J. Muntwyler, A. Cohen-Solal, and N. Freemantle Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe Eur J Heart Fail 6 2004 663 668
47. N.F. Murphy, C.R. Simpson, and F.A. McAlister National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland Heart 90 2004 1129 1136
48. P. Roman-Sanchez, P. Conthe, and J. Garcia-Alegria Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey QJM 98 2005 127 138
49. H. Krum, A.M. Tonkin, R. Currie, R. Djundjek, and C.I. Johnston Chronic heart failure in Australian general practice. The Cardiac Awareness Survey And Evaluation (CASE) Study Med J Aust 174 2001 439 444
50. W.N. Kasje, P. Denig, and R.E. Stewart Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study Eur J Clin Pharmacol 2005 11 (Electronic publication ahead of print, Mar.)
51. S.S. Rathore, J.M. Foody, and Y. Wang Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project Am Heart J 149 2005 121 128
52. F.M. Fruhwald, P. Rehak, and R. Maier Austrian survey of treating heart failure-AUSTRIA Eur J Heart Fail 6 2004 947 952
53. N.L. Smith, J.D. Chan, and T.D. Rea Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure Am Heart J 148 2004 710 717
54. J.J. McMurray Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? Eur Heart J 19 Suppl L 1998 L15 L21
55. G.L. Bakris, and M.R. Weir Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160 2000 685 693
56. J.J. McMurray, and E. O'Meara Treatment of heart failure with spironolactone - trial and tribulations N Engl J Med 351 2004 526 528
57. M.D. Witham, N.D. Gillespie, and A.D. Struthers Tolerability of spironolactone in patients with chronic heart failure - a cautionary message Br J Clin Pharmacol 58 2004 554 557
58. K.P. Tamirisa, K.D. Aaronson, and T.M. Koelling Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure Am Heart J 148 2004 971 978
59. J. McMurray, A. Cohen-Solal, and R. Dietz Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice Eur J Heart Fail 3 2001 495 502
60. J. Butler, P.G. Arbogast, and J. Daugherty Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge J Am Coll Cardiol 43 2004 2036 2043
61. A.P. Maggioni, G. Sinagra, and C. Opasich Beta blockers in patients with congestive heart failure: guided use in clinical practice Investigators. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience Heart 89 2003 299 305
62. L.G. Pont, M.C. Sturkenboom, and W.H. van Gilst Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000 Pharmacoepidemiol Drug Saf 12 2003 327 334
63. F.H. Rutten, D.E. Grobbee, and A.W. Hoes Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice Eur J Heart Fail 5 2003 337 344
64. S.P. McKee, S.J. Leslie, and J.P. LeMaitre Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians Eur J Heart Fail 5 2003 549 555
65. A. Di Lenarda, M. Scherillo, A.P. Maggioni TEMISTOCLE Investigators Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds-the TEMISTOCLE study Am Heart J 146 2003 E12
66. J.A. Franciosa, B.M. Massie, and M.A. Lukas Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry Am Heart J 148 2004 718 726
67. T.M. Rywik, S.L. Rywik, and J. Korewicki A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns Int J Cardiol 95 2004 177 184
68. J. Manyemba, A.A. Mangoni, K.W. Pettingale, and S.H. Jackson Determinants of failure to prescribe target doses of angiotensin-converting enzyme inhibitors for heart failure Eur J Heart Fail 5 2003 693 696
69. A.A. Bennett, J.A. Brien, and P.S. Macdonald Barriers to diagnosing and managing heart failure in primary care Med J Aust 182 2005 309
70. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
71. A. Stromberg, J. Martensson, and B. Fridlund Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial Eur Heart J 24 2003 1014 1023
72. L. Blue, and S. Stewart Improving outcomes in chronic heart failure second edition 2004 Br Med J Books London
73. I. Ekman, B. Fagerberg, and B. Andersson Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial Heart Lung 32 2003 3 9
74. P. Tandon, F.A. McAlister, and R.T. Tsuyuki The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes Arch Intern Med 164 2004 769 774
75. M. Ansari, M.G. Shlipak, and P.A. Heidenreich Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure Circulation 107 2003 2799 2804
76. G.C. Fonarow, M. Gheorghiade, and W.T. Abraham Importance of in-hospital initiation of evidence-based medical therapies for heart failure - a review Am J Cardiol 94 2004 1155 1160
77. A. Jain, P. Mills, and L.M. Nunn Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents Eur J Heart Fail 7 2005 405 410
78. L. Blue, and J. McMurray How much responsibility should heart failure nurses take? Eur J Heart Fail 7 2005 351 361
79. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819
80. J.N. Cohn, G. Johnson, and S. Ziesche A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
81. J.N. Cohn, D.G. Archibald, and S. Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a veterans administration cooperative study N Engl J Med 314 1986 1547 1552
82. F. Andersson, C. Cline, T. Ryden-Bergsten, and L. Erhardt Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing Pharmacoeconomics 15 1999 535 550